Head-to-head · WeighScore
Embody vs Lean Meds
The verdict
Lean Meds takes it — 81.8/100 to 76.5/100.
Lean Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lean Meds holds one price at every dose, names four dispensing pharmacies and its compounding class, and undercuts the field on both molecules.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Embody | Lean Meds |
|---|---|---|
| WeighScore | 76.5/100 | 81.8/100 |
| Grade | C | B− |
| Site position | #52 | #32 |
| Semaglutide | $79/mo (one-month injection; $828 annual prepay equals $69/mo) | $79/mo (one-month plan, flat at every dose) |
| Tirzepatide | $129/mo (one-month injection; $1,428 annual prepay equals $119/mo) | $109/mo (one-month plan, flat at every dose) |
| Coverage | State eligibility not fully published; confirm your location | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #52 · C
Strengths
- One-month injection offers at $79 semaglutide and $129 tirzepatide
- Separate monthly, three-, six- and twelve-month price tiers published
- OpenLoop care network and four pharmacy partners publicly named; individual assignment still needs confirmation
What to consider
- Payments are described as final at purchase except provider-initiated medical disqualification, with used services deducted
- Cancel at least 72 hours before renewal; unused prepaid months are not routinely refundable
- Homepage week counts differ from product month labels; confirm supply and charge dates
- Current catalog supports injections; no active oral-gum offer or universal state footprint confirmed
Site position #32 · B−
Strengths
- The price holds at every dose — stated as “same price, every dose” — so titration does not raise the bill
- $79 for semaglutide and $109 for tirzepatide on a one-month plan are at the low end of what this ranking records
- States its compounding class in the footer of every page: state-licensed 503A compounding pharmacies
- Names four dispensing pharmacies with addresses and phone numbers, and names the prescribing medical group
- A nutritionist and unlimited check-ins are included, and shipping is free
What to consider
- The $49 in the homepage hero is the twelve-month tier, not the month-to-month rate, and the same page carries a “price increases in” countdown with no dated deadline
- A homepage chip reads “no auto rebill” while the Terms describe automatic charging at recurring intervals until canceled
- An “eligible for insurance” chip sits against an FAQ calling the service self-pay and Terms barring reimbursement from any payor
- The refund page signs both “Leanmeds, Inc.” and “Leanmeds LLC”, chooses Florida law and then fixes venue in Fulton County, Georgia
- A satisfaction rating and a member count are published with no platform and no denominator
- No individual clinician or NPI is published — the medical group is named, its clinicians are not
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.